Insider · CIK 0001959622

Weaver Kirke

Reports to the SEC for 1 company · JERSEY CITY, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001959622

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-31	OGNOrganon & Co.M Exercise/Conversion	Gen. Counsel & Corp. Secy.	MExercise/Conversion	+6,201 sh	—	—	85,602.163
2026-03-31	OGNOrganon & Co.F Tax Payment	Gen. Counsel & Corp. Secy.	FTax Payment	−1,767 sh	$5.70	−$10.1K	83,835.163
2026-03-31	OGNOrganon & Co.M Exercise/Conversion	Gen. Counsel & Corp. Secy.	MExercise/Conversion	+12.3K sh	—	—	96,147.163
2026-03-31	OGNOrganon & Co.F Tax Payment	Gen. Counsel & Corp. Secy.	FTax Payment	−3,508 sh	$5.70	−$20K	92,639.163
2026-03-31	OGNOrganon & Co. · Restricted Stock UnitsA Award	Gen. Counsel & Corp. Secy.	AAward	+184K sh	—	—	183,639
2026-03-31	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Gen. Counsel & Corp. Secy.	MExercise/Conversion	−6,201 sh	—	—	0
2026-03-31	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Gen. Counsel & Corp. Secy.	MExercise/Conversion	−12.3K sh	—	—	24,625
2026-03-29	OGNOrganon & Co.M Exercise/Conversion	Gen. Counsel & Corp. Secy.	MExercise/Conversion	+7,757 sh	—	—	81,611.163
2026-03-29	OGNOrganon & Co.F Tax Payment	Gen. Counsel & Corp. Secy.	FTax Payment	−2,210 sh	$5.84	−$12.9K	79,401.163
2026-03-29	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Gen. Counsel & Corp. Secy.	MExercise/Conversion	−7,757 sh	—	—	7,757
2026-02-27	OGNOrganon & Co.A Award	Gen. Counsel & Corp. Secy.	AAward	+21.9K sh	—	—	74,414
2026-02-27	OGNOrganon & Co.F Tax Payment	Gen. Counsel & Corp. Secy.	FTax Payment	−6,815 sh	$7.17	−$48.9K	67,599
2026-02-27	OGNOrganon & Co.A Award	Gen. Counsel & Corp. Secy.	AAward	+6,186 sh	—	—	73,785
2026-02-27	OGNOrganon & Co.F Tax Payment	Gen. Counsel & Corp. Secy.	FTax Payment	−1,763 sh	$7.23	−$12.7K	73,854.163
2025-05-06	OGNOrganon & Co.P Purchase	Gen. Counsel & Corp. Secy.	PPurchase	+8,045 sh	$9.21	+$74.1K	52,489
2025-03-31	OGNOrganon & Co.M Exercise/Conversion	Gen. Counsel & Corp. Secy.	MExercise/Conversion	+7,757 sh	—	—	36,917
2025-03-31	OGNOrganon & Co.F Tax Payment	Gen. Counsel & Corp. Secy.	FTax Payment	−2,210 sh	$14.51	−$32.1K	34,707
2025-03-31	OGNOrganon & Co.M Exercise/Conversion	Gen. Counsel & Corp. Secy.	MExercise/Conversion	+6,200 sh	—	—	40,907
2025-03-31	OGNOrganon & Co.F Tax Payment	Gen. Counsel & Corp. Secy.	FTax Payment	−1,767 sh	$14.51	−$25.6K	39,140
2025-03-31	OGNOrganon & Co.M Exercise/Conversion	Gen. Counsel & Corp. Secy.	MExercise/Conversion	+3,125 sh	—	—	42,265
2025-03-31	OGNOrganon & Co.F Tax Payment	Gen. Counsel & Corp. Secy.	FTax Payment	−891 sh	$14.51	−$12.9K	41,374
2025-03-31	OGNOrganon & Co.M Exercise/Conversion	Gen. Counsel & Corp. Secy.	MExercise/Conversion	+4,294 sh	—	—	45,668
2025-03-31	OGNOrganon & Co.F Tax Payment	Gen. Counsel & Corp. Secy.	FTax Payment	−1,224 sh	$14.51	−$17.8K	44,444
2025-03-31	OGNOrganon & Co. · Stock Option (right to buy)A Award	Gen. Counsel & Corp. Secy.	AAward	+182K sh	—	—	181,518
2025-03-31	OGNOrganon & Co. · Restricted Stock UnitsA Award	Gen. Counsel & Corp. Secy.	AAward	+36.9K sh	—	—	36,937
2025-03-31	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Gen. Counsel & Corp. Secy.	MExercise/Conversion	−7,757 sh	—	—	15,514
2025-03-31	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Gen. Counsel & Corp. Secy.	MExercise/Conversion	−6,200 sh	—	—	6,200
2025-03-31	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Gen. Counsel & Corp. Secy.	MExercise/Conversion	−3,125 sh	—	—	0
2025-03-31	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Gen. Counsel & Corp. Secy.	MExercise/Conversion	−4,294 sh	—	—	0
2024-05-04	OGNOrganon & Co.M Exercise/Conversion	Gen. Counsel & Corp. Secy.	MExercise/Conversion	+1,248 sh	—	—	29,516
2024-05-04	OGNOrganon & Co.F Tax Payment	Gen. Counsel & Corp. Secy.	FTax Payment	−356 sh	$19.61	−$6,981.16	29,160
2024-05-04	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Gen. Counsel & Corp. Secy.	MExercise/Conversion	−1,248 sh	—	—	0
2024-03-31	OGNOrganon & Co.M Exercise/Conversion	Gen. Counsel & Corp. Secy.	MExercise/Conversion	+4,294 sh	—	—	22,825
2024-03-31	OGNOrganon & Co.F Tax Payment	Gen. Counsel & Corp. Secy.	FTax Payment	−1,224 sh	$18.80	−$23K	21,601
2024-03-31	OGNOrganon & Co.M Exercise/Conversion	Gen. Counsel & Corp. Secy.	MExercise/Conversion	+6,200 sh	—	—	27,801
2024-03-31	OGNOrganon & Co.F Tax Payment	Gen. Counsel & Corp. Secy.	FTax Payment	−1,767 sh	$18.80	−$33.2K	26,034
2024-03-31	OGNOrganon & Co.M Exercise/Conversion	Gen. Counsel & Corp. Secy.	MExercise/Conversion	+3,125 sh	—	—	29,159
2024-03-31	OGNOrganon & Co.F Tax Payment	Gen. Counsel & Corp. Secy.	FTax Payment	−891 sh	$18.80	−$16.8K	28,268
2024-03-31	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Gen. Counsel & Corp. Secy.	MExercise/Conversion	−4,294 sh	—	—	4,294
2024-03-31	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Gen. Counsel & Corp. Secy.	MExercise/Conversion	−3,125 sh	—	—	3,125
2024-03-31	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Gen. Counsel & Corp. Secy.	MExercise/Conversion	−6,200 sh	—	—	12,400
2024-03-29	OGNOrganon & Co. · Restricted Stock UnitsA Award	Gen. Counsel & Corp. Secy.	AAward	+23.3K sh	—	—	23,271
2024-03-29	OGNOrganon & Co. · Stock Option (right to buy)A Award	Gen. Counsel & Corp. Secy.	AAward	+95.3K sh	—	—	95,315
2024-02-28	OGNOrganon & Co.M Exercise/Conversion	Gen. Counsel & Corp. Secy.	MExercise/Conversion	+4,957 sh	—	—	20,138
2024-02-28	OGNOrganon & Co.F Tax Payment	Gen. Counsel & Corp. Secy.	FTax Payment	−1,607 sh	$18.04	−$29K	18,531
2024-02-28	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Gen. Counsel & Corp. Secy.	MExercise/Conversion	−4,957 sh	—	—	0
2024-02-22	OGNOrganon & Co.P Purchase	Gen. Counsel & Corp. Secy.	PPurchase	+2,720 sh	$18.36	+$49.9K	15,181
2023-05-04	OGNOrganon & Co.M Exercise/Conversion	Gen. Counsel & Corp. Secy.	MExercise/Conversion	+1,246 sh	—	—	12,816
2023-05-04	OGNOrganon & Co.F Tax Payment	Gen. Counsel & Corp. Secy.	FTax Payment	−355 sh	$24.24	−$8,605.2	12,461
2023-05-04	OGNOrganon & Co. · Restricted Stock UnitsM Exercise/Conversion	Gen. Counsel & Corp. Secy.	MExercise/Conversion	−1,246 sh	—	—	1,248

Recent filings

Accepted (ET)
Apr 24
Weaver Kirke0001628280-26-023146
SEC(opens sec.gov)
Mar 314
Weaver Kirke0001628280-26-022410
SEC(opens sec.gov)
Mar 34
Weaver Kirke0001628280-26-014222
SEC(opens sec.gov)
May 74
Weaver Kirke0001821825-25-000031
SEC(opens sec.gov)
Apr 24
Weaver Kirke0001821825-25-000010
SEC(opens sec.gov)

Companies

Organon & Co.Gen. Counsel & Corp. Secy.OGN

Address

C/O ORGANON & CO. 30 HUDSON STREET, FLOOR 33

JERSEY CITY, NJ, 07302